电邮这篇文章 Effect of Lithium Preparations on Cerebral Electrophysiological Activity in Rats
- 作者: Konenkov V.I.1, Rachkovskaya L.N.1, Letyagin A.Y.1, Suslov N.I.2, Shurlygina A.V.1, Robinson M.V.1, Korolev M.A.1, Kotlyarova A.A.1, Popova T.V.1, Rachkovskii E.E.1, Povet’eva T.N.2, Shilova N.V.2, Nesterova Y.V.2, Afanas’eva O.G.2, Kul’pin P.V.2
-
隶属关系:
- Research Institute of Clinical and Experimental Lymphology, Affiliated Branch of Federal Research Center of Cytology and Genetics, Siberian Division of the Russian Academy of Sciences
- E. D. Goldberg Research Institute of Pharmacology and Regenerative Medicine, Tomsk National Research Medical Center, Russian Academy of Sciences
- 期: 卷 165, 编号 4 (2018)
- 页面: 470-473
- 栏目: Article
- URL: https://ogarev-online.ru/0007-4888/article/view/240426
- DOI: https://doi.org/10.1007/s10517-018-4196-5
- ID: 240426
如何引用文章
开放存取
##reader.subscriptionAccessGranted##
订阅存取
详细
The study examined the effects of a novel neurotropic medication based on a lithium complex composed of lithium citrate, polymethylsiloxane, and aluminum oxide on electrophysiological parameters of the rat brain. In contrast to lithium carbonate (the reference drug), the novel preparation resulted in a wave-like dynamics of electrical activity in the visual cortex. Rhythmic photic stimulation of the rats treated with lithium carbonate resulted in appearance of the signs attesting to up-regulation of excitability of cerebral cortex in all examined ranges. In contrast, the complex lithium preparation diminished the delta power spectrum, which was the only affected frequency band. It is hypothesized that the complex lithium medication induces milder activation of the cerebral cortex in comparison with lithium carbonate. The novel medication composed of lithium citrate, aluminum oxide, and polymethylsiloxane, is characterized by greater efficacy and safety than the preparation based on inorganic lithium salt (lithium carbonate).
作者简介
V. Konenkov
Research Institute of Clinical and Experimental Lymphology, Affiliated Branch of Federal Research Center of Cytology and Genetics, Siberian Division of the Russian Academy of Sciences
Email: anna_v_s@mail.ru
俄罗斯联邦, Novosibirsk
L. Rachkovskaya
Research Institute of Clinical and Experimental Lymphology, Affiliated Branch of Federal Research Center of Cytology and Genetics, Siberian Division of the Russian Academy of Sciences
Email: anna_v_s@mail.ru
俄罗斯联邦, Novosibirsk
A. Letyagin
Research Institute of Clinical and Experimental Lymphology, Affiliated Branch of Federal Research Center of Cytology and Genetics, Siberian Division of the Russian Academy of Sciences
Email: anna_v_s@mail.ru
俄罗斯联邦, Novosibirsk
N. Suslov
E. D. Goldberg Research Institute of Pharmacology and Regenerative Medicine, Tomsk National Research Medical Center, Russian Academy of Sciences
Email: anna_v_s@mail.ru
俄罗斯联邦, Tomsk
A. Shurlygina
Research Institute of Clinical and Experimental Lymphology, Affiliated Branch of Federal Research Center of Cytology and Genetics, Siberian Division of the Russian Academy of Sciences
编辑信件的主要联系方式.
Email: anna_v_s@mail.ru
俄罗斯联邦, Novosibirsk
M. Robinson
Research Institute of Clinical and Experimental Lymphology, Affiliated Branch of Federal Research Center of Cytology and Genetics, Siberian Division of the Russian Academy of Sciences
Email: anna_v_s@mail.ru
俄罗斯联邦, Novosibirsk
M. Korolev
Research Institute of Clinical and Experimental Lymphology, Affiliated Branch of Federal Research Center of Cytology and Genetics, Siberian Division of the Russian Academy of Sciences
Email: anna_v_s@mail.ru
俄罗斯联邦, Novosibirsk
A. Kotlyarova
Research Institute of Clinical and Experimental Lymphology, Affiliated Branch of Federal Research Center of Cytology and Genetics, Siberian Division of the Russian Academy of Sciences
Email: anna_v_s@mail.ru
俄罗斯联邦, Novosibirsk
T. Popova
Research Institute of Clinical and Experimental Lymphology, Affiliated Branch of Federal Research Center of Cytology and Genetics, Siberian Division of the Russian Academy of Sciences
Email: anna_v_s@mail.ru
俄罗斯联邦, Novosibirsk
E. Rachkovskii
Research Institute of Clinical and Experimental Lymphology, Affiliated Branch of Federal Research Center of Cytology and Genetics, Siberian Division of the Russian Academy of Sciences
Email: anna_v_s@mail.ru
俄罗斯联邦, Novosibirsk
T. Povet’eva
E. D. Goldberg Research Institute of Pharmacology and Regenerative Medicine, Tomsk National Research Medical Center, Russian Academy of Sciences
Email: anna_v_s@mail.ru
俄罗斯联邦, Tomsk
N. Shilova
E. D. Goldberg Research Institute of Pharmacology and Regenerative Medicine, Tomsk National Research Medical Center, Russian Academy of Sciences
Email: anna_v_s@mail.ru
俄罗斯联邦, Tomsk
Yu. Nesterova
E. D. Goldberg Research Institute of Pharmacology and Regenerative Medicine, Tomsk National Research Medical Center, Russian Academy of Sciences
Email: anna_v_s@mail.ru
俄罗斯联邦, Tomsk
O. Afanas’eva
E. D. Goldberg Research Institute of Pharmacology and Regenerative Medicine, Tomsk National Research Medical Center, Russian Academy of Sciences
Email: anna_v_s@mail.ru
俄罗斯联邦, Tomsk
P. Kul’pin
E. D. Goldberg Research Institute of Pharmacology and Regenerative Medicine, Tomsk National Research Medical Center, Russian Academy of Sciences
Email: anna_v_s@mail.ru
俄罗斯联邦, Tomsk
补充文件
